These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38698180)

  • 1. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.
    Wang J; Yan L; Wang X; Jia R; Guo J
    Inflamm Res; 2024 Jul; 73(7):1123-1135. PubMed ID: 38698180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
    Wang X; Yan L; Guo J; Jia R
    Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of
    Sun J; Bai J; Jiang T; Gao Y; Hua Y
    RNA Biol; 2019 Dec; 16(12):1794-1805. PubMed ID: 31441370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.
    Liu L; Luo C; Luo Y; Chen L; Liu Y; Wang Y; Han J; Zhang Y; Wei N; Xie Z; Wu W; Wu G; Feng Y
    Oncogene; 2018 Jan; 37(1):86-94. PubMed ID: 28869607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1.
    Li D; Guo J; Jia R
    J Mol Biol; 2023 Mar; 435(6):167993. PubMed ID: 36736887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
    Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
    Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA.
    Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H
    J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing T Cell Exhaustion by Converting Membrane PD-1 to Its Soluble form in Jurkat Cells; Applying The CRISPR/Cas9 Exon Skipping Strategy.
    Yousefi-Najafabadi Z; Mehmandoostli Z; Asgari Y; Kaboli S; Falak R; Kardar GA
    Cell J; 2023 Sep; 25(9):633-644. PubMed ID: 37718766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform.
    Nasrin F; Rahman MA; Masuda A; Ohe K; Takeda J; Ohno K
    Sci Rep; 2014 Oct; 4():6841. PubMed ID: 25354590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
    Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
    J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells.
    Wang L; Gong S; Zhang X; Azhar Z; Chen J
    Gene; 2023 May; 866():147330. PubMed ID: 36871670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy.
    Scalet D; Balestra D; Rohban S; Bovolenta M; Perrone D; Bernardi F; Campaner S; Pinotti M
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):15-20. PubMed ID: 27639833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
    Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
    Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 Exon 3 Is a Hidden Switch of Its Expression and Function in Oral Cancer Cells.
    Yan L; Sun Y; Guo J; Jia R
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer.
    Zhu Y; Deng H; Chen X; Li H; Yang C; Li S; Pan X; Tian S; Feng S; Tan X; Matsuo M; Zhang Z
    Hum Genet; 2019 Jul; 138(7):771-785. PubMed ID: 31168774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.
    Guo J; Che X; Wang X; Jia R
    RSC Adv; 2018 Feb; 8(13):7159-7163. PubMed ID: 35540349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon-Specific U1s Correct SPINK5 Exon 11 Skipping Caused by a Synonymous Substitution that Affects a Bifunctional Splicing Regulatory Element.
    Dal Mas A; Fortugno P; Donadon I; Levati L; Castiglia D; Pagani F
    Hum Mutat; 2015 May; 36(5):504-12. PubMed ID: 25665175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ETFDH c.158A>G variation disrupts the balanced interplay of ESE- and ESS-binding proteins thereby causing missplicing and multiple Acyl-CoA dehydrogenation deficiency.
    Olsen RK; Brøner S; Sabaratnam R; Doktor TK; Andersen HS; Bruun GH; Gahrn B; Stenbroen V; Olpin SE; Dobbie A; Gregersen N; Andresen BS
    Hum Mutat; 2014 Jan; 35(1):86-95. PubMed ID: 24123825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
    Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
    Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.